Commonwealth Equity Services’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $78K | Buy |
+12,294
| New | +$78K | ﹤0.01% | 4100 |
|
2021
Q4 | – | Sell |
-8,332
| Closed | -$417K | – | 3674 |
|
2021
Q3 | $417K | Sell |
8,332
-4,072
| -33% | -$204K | ﹤0.01% | 2615 |
|
2021
Q2 | $781K | Sell |
12,404
-807
| -6% | -$50.8K | ﹤0.01% | 2105 |
|
2021
Q1 | $1.23M | Sell |
13,211
-799
| -6% | -$74.2K | ﹤0.01% | 1652 |
|
2020
Q4 | $1.26M | Buy |
14,010
+2,454
| +21% | +$220K | ﹤0.01% | 1518 |
|
2020
Q3 | $1.19M | Buy |
11,556
+1,724
| +18% | +$178K | ﹤0.01% | 1389 |
|
2020
Q2 | $777K | Buy |
9,832
+1,155
| +13% | +$91.3K | ﹤0.01% | 1581 |
|
2020
Q1 | $502K | Buy |
8,677
+775
| +10% | +$44.8K | ﹤0.01% | 1685 |
|
2019
Q4 | $426K | Buy |
+7,902
| New | +$426K | ﹤0.01% | 2034 |
|